Concepedia

Katy Rezvani

KR

Statistics

Publications

47

Citations

4.8K

H-Index

29

Active since

2000

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Imperial College London

Hammersmith Hospital

Baylor College of Medicine

National Institutes of Health

Katy Rezvani is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, life sciences, and hematology.

Publications per year

2000–2023

47

Publications

47

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

David Marín, Alexandra Bazeos, François-Xavier Mahon et al. · Journal of Clinical Oncology · 2010 · 901 citations · Full text

, , +13

Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>

Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch et al. · European Journal of Immunology · 2017 · 552 citations · Full text

, , +14

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

Partow Kebriaei, Harjeet Singh, M. Helen Huls et al. · Journal of Clinical Investigation · 2016 · 504 citations · Full text

, , +17

Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia

Kate Stringaris, Takuya Sekine, A. Khoder et al. · Haematologica · 2014 · 232 citations · Full text

, , +17

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

Nina Shah, Li Li, Jessica M McCarty et al. · British Journal of Haematology · 2017 · 224 citations · Full text

, , +17

1–5 of 47